Anemia Therapy
Darbepoetin alfa is novel erythropoiesis-stimulating protein
Published in Blood Weekly, November 20th, 2003
"Darbepoetin alfa is a novel erythropoiesis-stimulating protein developed for the treatment of anemia. It is a hyperglycosylated analog of recombinant human erythropoietin with the same mechanism of action as erythropoietin, but with a three-fold longer terminal half-life after intravenous administration than recombinant human erythropoietin and the native hormone both in animal models and in humans," a scientist in Spain reports.
"Clinical studies in patients with chronic renal failure either receiving or not receiving dialysis have shown that darbepoetin alfa is equivalent to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-11-20)
More Articles from Blood Weekly
- HIV/AIDS Cancer
Stem-cell autotransplantation safe for patients with HIV-related lymphoma - Immunology
Phospholipase C-L2 regulates B-cell receptor signaling - Multiple Myeloma
Triple stem-cell autotransplants effective for high-risk MM patients - Myeloproliferative Disease
IL-3 receptor signaling is dispensable for BCR-ABL-induced MPD - Stem-Cell Research
Umbilical cord vein is source of mesenchymal stem cells - Arthritis
Reconstructive surgery safe after stem-cell transplantation for refractory RA - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
